We’re extremely pleased to announce that Biotts has received a Money.pl Award nomination in the “Startup of the Year” category! The Money.pl Award recognizes companies and people that are proof of the fact that innovation and doing things differently combined with ethical, socially responsible behavior is a sure formula for success. More here. We’d like to take this opportunity […]

We have completed another phase of preclinical trials on a drug candidate that wasdeveloped by combining our carrier with a substance that fights diabetes. The first phase of clinical trials on humans are scheduled to begin in 2023. – We have obtained positive results from research on rodents large and small, which has allowed us […]

The Biotts team will take part in this year’s BIO-Europe Spring! BIO-Europe Spring is one of the key annual meetings for the biotech and pharma sectors. After two highly successful virtual editions that were organised in response to the COVID-19 pandemic, BIO-Europe Spring 2022 will continue to deliver outstanding online events for the life sciences […]

We’ve made the shortlist of 12 startups to earn a nomination to the final presentation stage of the Start-Up-Med contest, which is currently happening for a 4th time! This year its organizers had 50+ projects to choose from. Winners will be announced on March 3rd during a special Gala that’s part of the Health Challenges Congress (HCC) […]

Bankier.pl: The breakthrough transdermal system developed by Biotts makes it possible to deliver particles of medication that are dozens of times larger than what currently available solutions can get through the skin. The result? Drugs that can treat damaged tissue more precisely. As for the carrier itself, it is as harmless to the skin as […]

Puls Medycyny: 2022 is a year in which the biotech Biotts plans to invest several million PLN and introduce GMP and ISO standards. Among the company’s projects is a breakthrough transdermal system – a solution that makes it possible to transport drug molecules in doses that are several times larger than the capacity of currently […]